Literature DB >> 15260283

Unrecognised tuberculosis in HIV-infected patients: sputum culture is a useful tool.

S Swaminathan1, C N Paramasivan, S R Kumar, V Mohan, P Venkatesan.   

Abstract

Diagnosis of tuberculosis is challenging, especially in human immunodeficiency virus (HIV) positive persons who may have atypical clinical and radiographic features. We report the isolation of Mycobacterium tuberculosis from sputum samples of 10 (4%) HIV-positive persons who were asymptomatic with normal chest radiographs and negative sputum smears for acid-fast bacilli. Six of them had strongly positive tuberculin reactions while four were severely immunosuppressed. Our observation highlights the utility of routine sputum culture in the diagnosis of tuberculosis in high-risk individuals.

Entities:  

Mesh:

Year:  2004        PMID: 15260283

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  11 in total

1.  Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis.

Authors:  Amita Gupta; Aditya Chandrasekhar; Nikhil Gupte; Sandesh Patil; Ramesh Bhosale; Pradeep Sambarey; Shivahari Ghorpade; Uma Nayak; Laila Garda; Jayagowri Sastry; Renu Bharadwaj; Robert C Bollinger
Journal:  Clin Infect Dis       Date:  2011-09-21       Impact factor: 9.079

Review 2.  Improving the diagnosis of tuberculosis: From QuantiFERON to new techniques to diagnose tuberculosis infections.

Authors:  Amy Y Vittor; Joseph M Garland; David Schlossberg
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

Review 3.  Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.

Authors:  Neil A Martinson; Christopher J Hoffmann; Richard E Chaisson
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 4.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

Authors:  Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman
Journal:  Clin Microbiol Rev       Date:  2018-07-18       Impact factor: 26.132

Review 5.  Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response.

Authors:  Jacqueline M Achkar; Elizabeth R Jenny-Avital
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

6.  The use of anti-tuberculosis therapy for latent TB infection.

Authors:  Justin T Denholm; Emma S McBryde
Journal:  Infect Drug Resist       Date:  2010-07-21       Impact factor: 4.003

Review 7.  Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis.

Authors:  Katharina Kranzer; Rein Mgj Houben; Judith R Glynn; Linda-Gail Bekker; Robin Wood; Stephen D Lawn
Journal:  Lancet Infect Dis       Date:  2010-02       Impact factor: 25.071

8.  High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening.

Authors:  Tolu Oni; Rachael Burke; Relebohile Tsekela; Nonzwakazi Bangani; Ronnett Seldon; Hannah P Gideon; Kathryn Wood; Katalin A Wilkinson; Tom H M Ottenhoff; Robert J Wilkinson
Journal:  Thorax       Date:  2011-05-31       Impact factor: 9.139

9.  Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients.

Authors:  Matthew Bates; Justin O'Grady; Peter Mwaba; Lophina Chilukutu; Judith Mzyece; Busiku Cheelo; Moses Chilufya; Lukundo Mukonda; Maxwell Mumba; John Tembo; Mumba Chomba; Nathan Kapata; Andrea Rachow; Petra Clowes; Markus Maeurer; Michael Hoelscher; Alimuddin Zumla
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

10.  High prevalence of pulmonary tuberculosis but low sensitivity of symptom screening among HIV-infected pregnant women in South Africa.

Authors:  Christopher J Hoffmann; Ebrahim Variava; Modiehi Rakgokong; Katlego Masonoke; Martin van der Watt; Richard E Chaisson; Neil A Martinson
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.